(MoneyNewsWire.Net, December 07, 2017 ) The North America Preclinical in-vivo imaging market has been estimated at USD 283.10 Million in 2016 and is projected to reach USD 372.64 Million by 2021, at a CAGR of 5.65% during the forecast period from 2016 to 2021. Preclinical in-vivo imaging modalities are very crucial for researchers in observing changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes. It helps in gaining greater understanding of disease and therapeutic efficacy.
Browse market data tables and in-depth TOC of the North America Preclinical In-vivo Imaging Market to 2021 @ http://www.marketdataforecast.com/market-reports/north-america-preclinical-in-vivo-imaging-market-583/
The factors such as development of technologically advanced hybrid preclinical imaging systems such as PET/CT, PET/MRI, and PET/SPECT/CT, and growing acceptance of preclinical imaging as a legitimate drug development tool are the driving the market for Preclinical in-vivo imaging in North America. Declining NIH (National Institutes of Health) funding for life science research is constraining the market growth in this region.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/north-america-preclinical-in-vivo-imaging-market-583/request-sample
North America market for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the North America preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems. Bases on the reagents, the North America preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub-segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT robes.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/north-america-preclinical-in-vivo-imaging-market-583/inquire
North America Preclinical In-vivo Imaging Market Geographical Analysis
• United States
North America Preclinical In-vivo Imaging Market Leaders' Analysis
• Aspect Imaging
• Biospace Lab S.A.
• Bruker Corporation
• LI-COR Biosciences
• Mediso Ltd.
• MILabs B.V.
• MR Solutions Ltd
• TriFoil Imaging
• FUJIFILM VisualSonics, Inc.
Avail discount @ http://www.marketdataforecast.com/market-reports/north-america-preclinical-in-vivo-imaging-market-583/request-discount
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast